AimsBrands are critical to tobacco marketing. Industry stakeholders predicted that plain packaging, by removing key tangible branding dimensions, would restrict new products and brand differentiation. However, manufacturers respond innovatively to limit regulatory impact. This study investigates brand strategy following plain packaging's introduction to Australia. MethodsBrand portfolios were determined using 2006-15 tobacco ingredient reports. These detail the brand and variant names sold and are provided annually as part of a voluntary agreement between the Australian Government and leading manufacturers. Post-plain packaging brand ranges were verified using retail price lists and a supermarket retail audit using a method used previously to verify a period of pre-plain packaging data. ResultsThe verification process identified some data inaccuracies from one manufacturer which resulted in the issuing of corrected data. After plain packaging the leading manufacturers continued with extensive brand ranges differentiated by price. All launched new products. While total brand numbers fell from 29 to 24, the mean number of variants for the leading 12 brands grew from 8.9 to 9.7. Substantial variant name modifications occurred with 50 new or modified names in 2012-13. Among leading brands, the incidence of variant colour names increased from 49.5 to 79.3%. ConclusionsNew brands and variants were not inhibited by the introduction of plain packaging in Australia. After plain packaging, leading brand variant numbers expanded by 9 to 116 and colour variant names increased by 73.6% and became the normlighter colours (blue, gold and silver) dominated, perpetuating notions of less harmful cigarettes. [Correction added on 09 September 2016, after first online publication: The figures in the last sentence of the Abstract are now corrected from expanded by 116' to expanded by 9 to 116'.]
机构:
Univ Western Australia, Sch Anat Physiol & Human Biol, Respirol, Perth, WA 6009, AustraliaCurtin Univ, Fac Hlth Sci, Australian Council Smoking & Hlth, Perth, WA 6845, Australia
Eastwood, Peter
Mishima, Michiaki
论文数: 0引用数: 0
h-index: 0
机构:
Kyoto Univ, Grad Sch Med, Dept Resp Med, Asian Pacific Soc Respirol, Kyoto, JapanCurtin Univ, Fac Hlth Sci, Australian Council Smoking & Hlth, Perth, WA 6845, Australia
Mishima, Michiaki
Peters, Matthew
论文数: 0引用数: 0
h-index: 0
机构:
Macquarie Univ, Thorac Soc Australia & New Zealand, Fac Med & Hlth Sci, Sydney, NSW 2109, AustraliaCurtin Univ, Fac Hlth Sci, Australian Council Smoking & Hlth, Perth, WA 6845, Australia
机构:
Ctr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina
Hosp SAMIC El Calafate, Serv Med Familiar, El Calafate, ArgentinaCtr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina
Salgado, M. Victoria
Penko, Joanne
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA
Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USACtr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina
Penko, Joanne
Fernandez, Alicia
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA
Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USACtr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina
Fernandez, Alicia
Mejia, Raul
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina
Hosp Clin Jose San Martin, Programa Med Interna Gen, Buenos Aires, DF, ArgentinaCtr Estudios Estado & Soc, Area Salud Econ & Soc, Buenos Aires, DF, Argentina